Fulgent Genetics Inc (Fulgent) is a technology company that offers various comprehensive genetic testing to physicians. The company offers commercial genetic tests focused on cancers, cardiovascular diseases, neurological disorders, infectious diseases and paediatric diseases. It serves to medical institutions, hospitals and other laboratories. The company reports its operations under one reporting segment.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The company's R&D efforts focus on to develop its technology and new genetic tests. The key technology includes next generation sequencing technology. The company's R&D team comprises of highly qualified professionals with diverse expertise in various fields that are crucial to its business, including bioinformatics, genetics, software engineering, laboratory management, sales, and marketing. This team is responsible for conducting all of the company's research and development activities, including efforts to develop and curate its extensive library of genetic information and to expand its technology platform even further. In FY2022, the company spent US$28.9 million on its R&D efforts, which was 4.7% of its revenue which grew 19.4% YoY.